|
|
11 | (15) |
Preface |
|
15 | (2) |
|
Part One: Coronary quantitation by QCA and intracoronary ultrasound (QCU) |
|
|
|
Current and future developments in QCA and image fusion with IVUS |
|
|
17 | (14) |
|
|
|
|
|
|
|
Issues in the performance of quantitative coronary angiography in clinical research trials |
|
|
31 | (16) |
|
|
|
|
|
|
|
The cost-effectiveness of QCA in interventional cardiology |
|
|
47 | (14) |
|
|
|
|
3-D coronary angiography: improving visualization strategy for coronary interventions |
|
|
61 | (18) |
|
|
|
Quantitative coronary ultrasound: state of the art |
|
|
79 | (16) |
|
|
|
|
|
|
Part Two: Angiographic trials |
|
|
|
Genetic factors in the progression of atherosclerosis and response to cholesterol lowering drugs |
|
|
95 | (6) |
|
|
|
|
|
|
Effect of lipid lowering therapy on myocardial perfusion; results from REGRESS and LAARS |
|
|
101 | (12) |
|
|
|
|
|
How well does angiographic progression correlate with clinical events? |
|
|
113 | (6) |
|
|
How should future angiographic trials be designed? |
|
|
119 | (14) |
|
|
|
|
Part Three: Progress in intravascular ultrasound (IVUS) |
|
|
|
Applications of intravascular ultrasound in cardiology |
|
|
133 | (16) |
|
|
|
Cardiovascular flow measurements with IVUS |
|
|
149 | (10) |
|
|
|
|
|
Antonius F.W. van der Steen |
|
|
Optimal ultrasound guided balloon angioplasty |
|
|
159 | (12) |
|
|
|
|
|
|
|
|
Prediction of restenosis by IVUS |
|
|
171 | (12) |
|
|
|
|
|
Assessment of plaque composition using intravascular ultrasound |
|
|
183 | (14) |
|
|
|
Part Four: Magnetic resonance (MR) coronary and vascular imaging |
|
|
|
Magnetic resonance in cardiology: which clinical questions can be answered now and in the near future? |
|
|
197 | (10) |
|
|
Real-Time Cardiovascular MR Imaging |
|
|
207 | (14) |
|
|
Left ventricular function under stress conditions by MRI |
|
|
221 | (12) |
|
|
|
|
Quantitation of global and regional left ventricular function by MRI |
|
|
233 | (14) |
|
|
|
Status of myocardial perfusion assessment by MRI |
|
|
247 | (14) |
|
|
|
Part Five: Nuclear cardiovascular imaging |
|
|
|
Nuclear cardiology: which clinical questions can be answered now and in the future? |
|
|
261 | (18) |
|
|
State-of-the-art in myocardial perfusion SPECT imaging |
|
|
279 | (14) |
|
|
|
|
|
State of the art in the assessment of ventricular function by gated SPECT |
|
|
293 | (6) |
|
|
Assessment of myocardial viability by FDG imaging with SPECT |
|
|
299 | (12) |
|
|
|
|
|
|
|
|
What are the niches for SPECT versus PET versus MRI? |
|
|
311 | (12) |
|
|
|
|
Part Six: Echocardiography |
|
|
|
Echocardiography: where are we now and where are we heading? |
|
|
323 | |
|
|
Intravenous echocontrast for assessment of left ventricular function and perfusion |
|
|
33 | (318) |
|
|
State-of-the-Art. Stress echocardiography entering the next millennium |
|
|
351 | (12) |
|
|
|
|
Overview of automatedquantitation techniques in 2D echocardiography |
|
|
363 | (14) |
|
|
|
|
|
Doppler myocardial imaging |
|
|
377 | (14) |
|
|
Carotid intima-media thickness measurement: predictor of future cardiovascular disease |
|
|
391 | (10) |
|
|
|
|
Part Seven: Cine and spiral CT coronary imaging |
|
|
|
What is the current role of electron beam computed tomography in coronary imaging? |
|
|
401 | (10) |
|
|
|
|
Magnetic resonance and electron beamtomography coronary angiography |
|
|
411 | (8) |
|
|
|
|
|
|
|
|
Color section |
|
419 | (12) |
Index |
|
431 | |